These articles have been hand-picked by the editors of Vascular News, these articles offer insights and perspectives on the latest trends and best practices within the vascular community, and we hope that they will be of interest to you.
Speaking to CX Live, Eric Secemsky (Boston, USA) delves into the emerging use of intravascular ultrasound (IVUS) in the peripheral procedural phases—outlining contemporary studies providing…
February’s top 10 includes the announcement that Abbott is to acquire Cardiovascular Systems, results of the PRESERVE study on the safety and effectiveness of inferior…
Kim G Smolderen and Carlos Mena-Hurtado Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular…
At the 2022 Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (23–25 November, Brighton, UK), Srinivasa Rao Vallabhaneni (University of Liverpool, Liverpool, UK) delivered…
The UK National Vascular Registry (NVR) recently published its 2022 annual report—the 10th since the registry was launched in 2013—highlighting important outcome data for vascular…
The UK’s national abdominal aortic aneurysm (AAA) screening programme is fast approaching its 10th anniversary—a milestone that Akhtar Nasim (Sheffield Vascular Institute, Sheffield, Sheffield, UK)…
Nellix EVAS system In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines…
Athanasios Saratzis Athanasios Saratzis (University of Leicester, Leicester, UK) speaks to Vascular News about the EVOCC trial, which he hopes will dispel patient and physician…
AVS has announced that it raised US$20 million in Series B financing, which the company says will accelerate clinical trial timelines for its device for…
Cardiovascular Systems (CSI) announced that Innova Vascular (Innova) has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its thrombectomy…
Aisha Shaikh Aisha Shaikh (Memorial Sloan Kettering Cancer Centre, New York, USA) has staked out a claim that, though hypotension was “associated” with arteriovenous access…
Lara Barghout ReCor Medical and its parent company Otsuka Medical Devices have announced the appointment of Lara Barghout as president and chief executive officer of…
Despite his initial intention to become a transplant surgeon, Markus Steinbauer (Krankenhaus Barmherzige Brüder, Regensburg, Germany) recalls how the rise of endovascular techniques, and the…
Rob Sayers presenting at the VSGBI annual scientific meeting 2022 The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific…
During a late-breaking clinical trials session at the 2022 Vascular Interventional Advances (VIVA) conference (31 October–3 November, Las Vegas, USA), Mehdi Shishehbor (University Hospitals Harrington…
Thomas Maldonado (New York University Medical Center, New York, USA) speaks to Vascular News at the 2022 Vascular Interventional Advances (VIVA) conference (31 October–3 November,…
L-R: Alik Farber, Matthew Menard, and Kenneth Rosenfield The first results from the BEST-CLI randomised controlled trial (RCT) of 1,830 patients show that surgical bypass…
Hanaa Dakour Aridi takes to the MVSS 2022 podium Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used…
Christopher Kwolek at VIVA 2022 Christopher Kwolek (Massachusetts General Hospital and Harvard Medical School, Boston, USA) presented five-year results from the LEOPARD randomised controlled trial…
Ehrin Armstrong at VIVA 2022 The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical)…
Daniel Clair presents six-month LimFlow data Six-month results from the PROMISE II trial of the LimFlow deep vein arterialisation system (LimFlow) showed an overall amputation-free…
Kenneth Rosenfield presents the new data at VIVA 2022 In the TRANSCEND clinical trial, the SurVeil drug-coated balloon (DCB; Surmodics) demonstrated “excellent efficacy and safety”…
Mehdi Shishehbor presents the new data at VIVA 2022 A patient-level, propensity-adjusted comparison of three-year results from a quartet of prospective, multicentre trials support the…
Michael Lichtenberg at VIVA 2022 At the 2022 Vascular Interventional Advances (VIVA) meeting (31 October–3 November, Las Vegas, USA), Michael Lichtenberg (Arnsberg Clinic, Arnsberg, Germany)…
Joseph S Coselli (Baylor College of Medicine, Houston, USA) speaks to Vascular News about his career to date. Despite initially planning to follow in his…
Alexander Zimmermann (University Hospital Zurich, Zurich, Switzerland) tells Vascular News about his career to date, beginning with a rotation in vascular surgery that opened up…
“As vascular surgeons, we never stop learning,” Palma Shaw tells Vascular News. This is one of the key attractions of the specialty for Shaw, who…
“Go for it!” Michael Jenkins urges anyone looking to start a career in medicine, highlighting that the COVID-19 pandemic has put into sharp focus its…
Andy Watts/NB Illustration “I would say that the future is incredibly bright for cardiovascular surgeons,” Joseph E Bavaria tells Vascular News. The 52nd president of…
alisonlang.com “There is no doubt in my mind that working together rather than competing against each other will not only be in our best interests…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
